These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8628721)

  • 1. Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Prostate; 1996 Mar; 28(3):182-94. PubMed ID: 8628721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):391-9. PubMed ID: 9449242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNcaP prostatic adenocarcinoma cells.
    Goossens K; Esquenet M; Swinnen JV; Manin M; Rombauts W; Verhoeven G
    Mol Cell Endocrinol; 1999 Sep; 155(1-2):9-18. PubMed ID: 10580834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Mol Cell Endocrinol; 1995 Mar; 109(1):105-11. PubMed ID: 7540569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids stimulate lipid synthesis and accumulation in LNCaP prostatic adenocarcinoma cells.
    Esquenet M; Swinnen JV; Van Veldhoven PP; Denef C; Heyns W; Verhoeven G
    Mol Cell Endocrinol; 1997 Dec; 136(1):37-46. PubMed ID: 9510066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive effects of 9-cis-retinoic acid and androgen on proliferation, differentiation, and apoptosis of LNCaP prostate cancer cells.
    Eskra JN; Kuiper JW; Walden PD; Bosland MC; Özten N
    Eur J Cancer Prev; 2017 Jan; 26(1):71-77. PubMed ID: 26886237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells.
    Fong CJ; Sutkowski DM; Braun EJ; Bauer KD; Sherwood ER; Lee C; Kozlowski JM
    J Urol; 1993 May; 149(5):1190-4. PubMed ID: 7683344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model.
    Gleave ME; Sato N; Sadar M; Yago V; Bruchovsky N; Sullivan L
    J Cell Biochem; 1998 Jun; 69(3):271-81. PubMed ID: 9581866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3.
    Murthy S; Marcelli M; Weigel NL
    Prostate; 2003 Sep; 56(4):293-304. PubMed ID: 12858358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
    Zhao XY; Peehl DM; Navone NM; Feldman D
    Endocrinology; 2000 Jul; 141(7):2548-56. PubMed ID: 10875257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
    Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
    Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
    Bauer JA; Thompson TA; Church DR; Ariazi EA; Wilding G
    Prostate; 2003 May; 55(3):159-67. PubMed ID: 12692781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
    Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
    Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid modulates the anti-proliferative effect of 1,25-dihydroxyvitamin D3 in cultured human epidermal keratinocytes.
    Segaert S; Garmyn M; Degreef H; Bouillon R
    J Invest Dermatol; 1997 Jul; 109(1):46-54. PubMed ID: 9204954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
    Danesi R; Nardini D; Basolo F; Del Tacca M; Samid D; Myers CE
    Mol Pharmacol; 1996 Jun; 49(6):972-9. PubMed ID: 8649357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1.
    Blutt SE; Allegretto EA; Pike JW; Weigel NL
    Endocrinology; 1997 Apr; 138(4):1491-7. PubMed ID: 9075707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both retinoids and androgens are required to maintain or promote functional differentiation in reaggregation cultures of human prostate epithelial cells.
    Goossens K; Deboel L; Swinnen JV; Roskams T; Manin M; Rombauts W; Verhoeven G
    Prostate; 2002 Sep; 53(1):34-49. PubMed ID: 12210478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.
    Soto AM; Lin TM; Sakabe K; Olea N; Damassa DA; Sonnenschein C
    Oncol Res; 1995; 7(10-11):545-58. PubMed ID: 8866667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.